The world is taking notice—9 Nanjing companies have secured a place on the 2025 Hurun Global Unicorn List, placing the city 7th nationwide.

They represent a diverse innovation portfolio: three biotech leaders, alongside disruptors in semiconductors, EVs, logistics, and the shared economy. It’s a reflection of a city that combines research depth with industrial strength.

In the field of life sciences, Nanjing currently ranks among the top five cities in China in terms of new drug approvals. Over the past six months alone, several notable developments have taken place: TransThera Sciences (Nanjing) Inc. successfully listed on the Hong Kong Stock Exchange (HKEX), Scage Automotive made its debut on Nasdaq, and Hansong (Nanjing) Technology passed the IPO review for ChiNext.

Nanjing’s innovation story continues to accelerate—powered by talent, policy, and a complete industrial ecosystem.